152 related articles for article (PubMed ID: 27050560)
1. Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
Zhang J; Wang P; Ji W; Ding Y; Lu X
Int J Neurosci; 2017 Mar; 127(3):210-217. PubMed ID: 27050560
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
3. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
5. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
Zhong J; Li B
J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.
Fan X; Wang Y; Zhang C; Liu X; Qian Z; Jiang T
J Neuroimmunol; 2016 May; 294():27-31. PubMed ID: 27138095
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
9. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
12. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
Wang L; Wu L; Wu J
J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
[TBL] [Abstract][Full Text] [Related]
14. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
Ding D; Song T; Jun W; Tan Z; Fang J
Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
18. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
[TBL] [Abstract][Full Text] [Related]
19. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.
Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S
J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
Chen T; Wang XY; Li C; Xu SJ
Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
